Email Address
info@myglp1store.com
Phone Number
+1 470-535-5258
Our Location
8102 Blanding blvd. Jacksonville, FL 32244
info@myglp1store.com
+1 470-535-5258
8102 Blanding blvd. Jacksonville, FL 32244
Price range: $238.00 through $299.98
In clinical research, adults with overweight or obesity received once-weekly subcutaneous doses of Survodutide ranging from 0.6 mg to 4.8 mg, with some groups gradually titrated, compared to placebo, for up to 46 weeks.
The highest-dose group (4.8 mg) achieved an average weight reduction of approximately –14.9% at 46 weeks (placebo-adjusted ~–12.1%). All trial dosing was administered once weekly via subcutaneous injection.
Based on published study protocols:
Weeks 1–20: Start at ~0.6 mg weekly, gradually increasing toward ~2.4–3.6 mg
Weeks 21–46: Maintenance at ~2.4 mg, 3.6 mg, or 4.8 mg weekly
Phase 3 design: Ongoing studies include escalation to ~6.0 mg weekly
⚠️ Important Cautions
Survodutide is not approved for general weight-loss use.
Doses above reflect clinical trial research only and are not official prescribing guidelines.
Long-term safety, maintenance dosing, and higher-dose effects beyond the studied ranges are not fully established.
Most common side effects were gastrointestinal (nausea, vomiting); ~25% of participants discontinued treatment versus ~4% in placebo.
Any off-trial use or dose escalation beyond studied ranges carries significant safety, ethical, and legal risks.
The Survodutide Deal – Buy 2 Get 1 Free provides researchers with a reliable supply of Survodutide to conduct safe, controlled trials, replicate studies, or explore dose escalation under professional guidance. This bundle ensures continuity and consistency for research while highlighting that all use must adhere to ethical and clinical standards.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
The Survodutide Weight Loss Deal is a Buy 2 Get 1 Free bundle designed for researchers and labs studying weight management and fat reduction. Survodutide is a powerful peptide that helps control appetite, stabilize blood sugar, and boost energy use by activating GLP-1 and GIP receptors. As a result, it supports gradual, safe, and measurable fat loss.
At MYGLP1 Store, we supply authentic Survodutide from trusted manufacturers. This deal ensures researchers and labs have enough peptide supply to run extended studies, repeat experiments, or explore dose escalation safely. Many users report better appetite control, steady energy, and visible fat reduction when used consistently.
Survodutide mimics natural GLP-1 and GIP hormones. It signals your body to burn fat efficiently and control hunger. Clinical studies show that it helps adults with overweight or obesity achieve gradual, sustainable weight loss. Additionally, this Buy 2 Get 1 Free bundle guarantees a consistent supply for ongoing research.
We recommend using Survodutide only under professional supervision. Always follow research or clinical protocols. Moreover, pairing the peptide with balanced nutrition and regular activity produces better results. This Survodutide Deal ensures researchers can maintain consistent studies and accurate outcomes.
Take advantage of the Buy 2 Get 1 Free offer to secure high-quality Survodutide for your research. Order now from MYGLP1 Store, your trusted source for premium GLP-1 and GIP peptides.
In clinical research, adults with overweight or obesity received once-weekly subcutaneous doses of Survodutide ranging from 0.6 mg to 4.8 mg, with some groups gradually titrated, compared to placebo, for up to 46 weeks.
The highest-dose group (4.8 mg) achieved an average weight reduction of approximately –14.9% at 46 weeks (placebo-adjusted ~–12.1%). All trial dosing was administered once weekly via subcutaneous injection.
Based on published study protocols:
Weeks 1–20: Start at ~0.6 mg weekly, gradually increasing toward ~2.4–3.6 mg
Weeks 21–46: Maintenance at ~2.4 mg, 3.6 mg, or 4.8 mg weekly
Phase 3 design: Ongoing studies include escalation to ~6.0 mg weekly
⚠️ Important Cautions
Survodutide is not approved for general weight-loss use.
Doses above reflect clinical trial research only and are not official prescribing guidelines.
Long-term safety, maintenance dosing, and higher-dose effects beyond the studied ranges are not fully established.
Most common side effects were gastrointestinal (nausea, vomiting); ~25% of participants discontinued treatment versus ~4% in placebo.
Any off-trial use or dose escalation beyond studied ranges carries significant safety, ethical, and legal risks.
The Survodutide Deal – Buy 2 Get 1 Free provides researchers with a reliable supply of Survodutide to conduct safe, controlled trials, replicate studies, or explore dose escalation under professional guidance. This bundle ensures continuity and consistency for research while highlighting that all use must adhere to ethical and clinical standards.
